Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 30, 2024

Total Value ($000): $388,247

Holdings (16)

— ALPINE IMMUNE SCIENCES INC 23.0%

Value ($000) $89,316 Shares 2,253,183 Est. Cost $13.47 Unrealized —

— MERUS N V 17.5%

Value ($000) $67,951 Shares 1,509,007 Est. Cost $29.71 Unrealized —

STOK STOKE THERAPEUTICS INC 12.9%

Value ($000) $49,907 Shares 3,696,820 Est. Cost $5.70 Unrealized +6.4%

TCRX TSCAN THERAPEUTICS INC 10.7%

Value ($000) $41,483 Shares 5,224,600 Est. Cost $2.68 Unrealized +134.8%

CABA CABALETTA BIO INC 9.2%

Value ($000) $35,536 Shares 2,082,973 Est. Cost $3.64 Unrealized +489.5%

GHRS GH RESEARCH PLC 9.1%

Value ($000) $35,291 Shares 3,310,563 Est. Cost $8.57 Unrealized -7.3%

CCCC C4 THERAPEUTICS INC 7.6%

Value ($000) $29,695 Shares 3,634,662 Est. Cost $3.25 Unrealized +138.5%

SLN SILENCE THERAPEUTICS PLC 2.9%

Value ($000) $11,375 Shares 526,642 Est. Cost $16.33 Unrealized —

AUTL AUTOLUS THERAPEUTICS PLC 2.3%

Value ($000) $8,869 Shares 1,390,160 Est. Cost $3.43 Unrealized —

— PASSAGE BIO INC 1.7%

Value ($000) $6,542 Shares 4,845,871 Est. Cost $1.34 Unrealized —

— KINNATE BIOPHARMA INC 1.4%

Value ($000) $5,270 Shares 1,981,106 Est. Cost $10.62 Unrealized —

IBIO IBIO 0.6%

Value ($000) $2,436 Shares 600,000 Est. Cost $1.26 Unrealized 0.0%

— NEKTAR THERAPEUTICS 0.5%

Value ($000) $1,933 Shares 2,068,842 Est. Cost $0.62 Unrealized —

— PIERIS PHARMACEUTICALS INC 0.4%

Value ($000) $1,608 Shares 8,779,162 Est. Cost $1.23 Unrealized —

— BIONOMICS LIMITED 0.2%

Value ($000) $839 Shares 814,467 Est. Cost $2.69 Unrealized —

CNTA CENTESSA PHARMACEUTICALS PLC 0.1%

Value ($000) $197 Shares 17,400 Est. Cost $11.30 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ALPINE IMMUNE SCIENCES INC	2,253,183	$89,316	23.0%	$13.47	—	—	02083G100
—	MERUS N V	1,509,007	$67,951	17.5%	$29.71	—	—	N5749R100
STOK	STOKE THERAPEUTICS INC	3,696,820	$49,907	12.9%	$5.70	+6.4%	—	86150R107
TCRX	TSCAN THERAPEUTICS INC	5,224,600	$41,483	10.7%	$2.68	+134.8%	—	89854M101
CABA	CABALETTA BIO INC	2,082,973	$35,536	9.2%	$3.64	+489.5%	—	12674W109
GHRS	GH RESEARCH PLC	3,310,563	$35,291	9.1%	$8.57	-7.3%	—	G3855L106
CCCC	C4 THERAPEUTICS INC	3,634,662	$29,695	7.6%	$3.25	+138.5%	—	12529R107
SLN	SILENCE THERAPEUTICS PLC	526,642	$11,375	2.9%	$16.33	—	—	82686Q101
AUTL	AUTOLUS THERAPEUTICS PLC	1,390,160	$8,869	2.3%	$3.43	—	—	05280R100
—	PASSAGE BIO INC	4,845,871	$6,542	1.7%	$1.34	—	—	702712100
—	KINNATE BIOPHARMA INC	1,981,106	$5,270	1.4%	$10.62	—	—	49705R105
IBIO	IBIO	600,000	$2,436	0.6%	$1.26	0.0%	—	451033708
—	NEKTAR THERAPEUTICS	2,068,842	$1,933	0.5%	$0.62	—	—	640268108
—	PIERIS PHARMACEUTICALS INC	8,779,162	$1,608	0.4%	$1.23	—	—	720795103
—	BIONOMICS LIMITED	814,467	$839	0.2%	$2.69	—	—	09063M205
CNTA	CENTESSA PHARMACEUTICALS PLC	17,400	$197	0.1%	$11.30	—	—	152309100